Literature DB >> 16553585

Effects of an osmotically active agent on colonic transit.

S M Skoog1, A E Bharucha, M Camilleri, D D Burton, A R Zinsmeister.   

Abstract

It is unknown if sorbitol, a widely used laxative agent, accelerates colonic transit, and if these effects are modified by concomitant meal ingestion. Colonic transit was assessed by (111)In scintigraphy in 40 healthy subjects. After a 24-h scan, subjects received sorbitol (30 mL of 70% solution) or dextrose (30 mL of 70% solution), administered with or without a meal. Colonic transit, breath hydrogen excretion, and symptom scores were recorded for 4 h thereafter. VAS scores for flatulence, but not other symptoms increased (P = 0.004) by 13.1 +/- 6.3 mm (mean +/- SEM) on a 100 mm scale after sorbitol alone or sorbitol with a meal (by 18.9 +/- 7.2 mm), but not after dextrose. After adjusting for GC(24), sorbitol accelerated (P < 0.001) colonic transit (GC(28) = 3.0 +/- 0.3) compared with dextrose (GC(28) = 2.2 +/- 0.2), regardless of meal ingestion. Breath hydrogen excretion was correlated with the change in colonic transit (r = 0.52, P < 0.01) and with flatulence (r = 0.45, P = 0.003) after sugar ingestion. In healthy subjects, sorbitol accelerated colonic transit and increased flatulence but not other symptoms within 4 h, regardless of meal intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553585     DOI: 10.1111/j.1365-2982.2006.00757.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

Review 1.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

2.  The approach to diagnosis and treatment of chronic constipation: suggestions for a general practitioner.

Authors:  Pierre Pare
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

Review 3.  Behavioural and new pharmacological treatments for constipation: getting the balance right.

Authors:  Michael Camilleri; Adil E Bharucha
Journal:  Gut       Date:  2010-09       Impact factor: 23.059

4.  A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: implications for MR enterography.

Authors:  Adil E Bharucha; Jeff L Fidler; James E Huprich; Shiva K Ratuapli; David R Holmes; Stephen J Riederer; Alan R Zinsmeister
Journal:  Eur J Radiol       Date:  2014-08-17       Impact factor: 3.528

Review 5.  Mechanisms, Evaluation, and Management of Chronic Constipation.

Authors:  Adil E Bharucha; Brian E Lacy
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

6.  Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".

Authors:  Q Manyan Fung; Andrew Szilagyi
Journal:  Int J Inflam       Date:  2012-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.